BackgroundTobacco use is significantly more prevalent among individuals with schizophrenia spectrum disorders (SSD) compared to the general population, contributing to elevated rates of premature mortality from…
BackgroundAdult attention-deficit hyperactivity disorder (ADHD) diagnostic pathways in England are under sustained pressure. Demand has risen, waiting times have lengthened, service models remain fragmented, workforce…
BackgroundThis study primarily investigates the intervention effects of different models on children with autism.MethodsA total of 132 autistic children were recruited and assigned to three intervention models…
Sleep duration and weekday–weekend sleep variability are increasingly recognised as important determinants of mental health. However, evidence from African populations on the relationship between sleep patterns and…
Background As a core diagnostic criterion for autism spectrum disorder (ASD), sensory differences may have profound implications for the quality of life among autistic individuals. However, little is known about the…
Background Although mental pain is widely regarded as a central catalyst for suicidal behavior, the relationship between physical pain sensitivity and suicidal ideation remains poorly characterized. This study examines…
Iron deficiency anemia (IDA) has been increasingly associated with neuropsychiatric conditions, including major depressive disorder (MDD). However, demographic variation in documented MDD diagnoses among patients with…
Background Empathy, encompassing cognitive mentalizing and affective sharing, is pivotal for navigating social interaction during adolescence. However, the characteristics and its electrophysiological mechanisms of…
Schizophrenia is increasingly conceptualized as a disorder of large-scale brain network integration, yet how specific symptom phenotypes relate to reproducible resting-state functional connectivity (rsFC) signatures…
(MedPage Today) -- An investigational antifungal was associated with clinical improvements in a majority of patients with disseminated coccidioidomycosis (DCM) who failed standard treatments, according to an open-label…
Pediatricians who participated in the collaborative mental health program at Ann & Robert H. Lurie Children's Hospital of Chicago were more likely to diagnose and treat anxiety and depression in children without relying…
(MedPage Today) -- Caffeine consumption can be safely tolerated in reasonable amounts in most people, according to a review by the American Heart Association (AHA). "The convergence of evidence from large cohort studies…
(MedPage Today) -- The Agency for Healthcare Research and Quality (AHRQ) cut dozens of grants last week, issuing what appeared to be batch termination notices to researchers. Termination letters shared with MedPage Today…
(MedPage Today) -- Federal health officials said Monday they remain focused on lettuce from Taylor Farms as the source of a multistate outbreak of the diarrhea-causing parasite Cyclospora, despite inaccurate test results…
(MedPage Today) -- Treatment with investigational duvakitug appeared to improve remission rates among patients with ulcerative colitis and endoscopic response rates in those with Crohn's disease, results from two cohorts…
(MedPage Today) -- Spouses of people with dementia had a higher risk of developing dementia themselves, a matched cohort study of nearly 1 million married people in Taiwan showed. Compared with unexposed spouses, both…
(MedPage Today) -- Having dismantled the U.S. Agency for International Development and decimated the CDC's global health capacities, the Trump administration has resorted to a blunt instrument to protect the American…
A CU Anschutz study exploring more than 10,000 youth suicides suggests gaps in the system are costing kids' lives, pointing to a critical need for new approaches in responding to the national crisis.
(MedPage Today) -- The market for compounded GLP-1 drugs remained robust despite the end of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) shortages, with many facilities adding ingredients like B…
Severe flooding may contribute to higher mortality rates from opioid use in rural Appalachia, according to a study by researchers at Penn State. The findings—published in the Proceedings of the National Academy of…
New data show APOE4 worsens early sleep disruption in Alzheimer models; CN-105 and zolpidem restore deep sleep and may slow amyloid buildup.
Around a third of people with schizophrenia don't respond to antipsychotics. This mega-analysis of individual patient data asks whether brain metabolites, measured with magnetic resonance spectroscopy ...
Last week, Eli Lilly, the world’s most valuable pharmaceutical company, agreed to buy Thiel-backed psychedelic drug developer AtaiBeckley for up to $3.8bn. Japan’s Otsuka Pharmaceutical acquired ...
Although hearing loss is associated with a greater risk for dementia, those who rated their hearing aids as fair or poor saw no significant difference in risk as hearing-impaired adults with no hearing aids, according to…
Weight bias and stigma have been increasingly recognized as a major barrier to effective obesity care and the mental well-being of patients.Patients with obesity often encounter judgement, negative assumptions and…
FDA grants Fast Track to Acadia’s remlifanserin for Alzheimer disease psychosis, targeting hallucinations and delusions as RADIANT trial advances toward 2026 data.
Why DSM reforms miss psychiatry’s key flaw: weak diagnostic validity—and how evidence-based validators could reshape diagnosis, research, and care.
Eli Lilly's acquisition of AtaiBeckley for up to $3.8 billion, marks a pivotal moment for psychedelic medicine.
An international team led by the Central Institute of Mental Health in Mannheim has presented the largest genome-wide association study on borderline personality disorder to date. Data from about ...
SANTA ANA, CA - July 20, 2026 - PRESSADVANTAGE - Moment of Clarity has published a new educational resource designed to ...